Nxera Pharma
4565.T
$9.00
Share price
9.46%
Change (1 day)
-48.89%
Change (1 year)
Categories
EPS for Nxera Pharma (4565.T)
EPS in 2024 (TTM): -$1.33
According to Nxera Pharma's latest financial reports the company's current EPS (TTM) is -$1.40. In 2023 the company made an earnings per share (EPS) of -$1.09 a decrease over its 2022 EPS that were of $0.06277.
EPS history for Nxera Pharma from 2005 to 2024
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2024 (TTM) | -$1.33 | 22.2% |
| 2023 | -$1.09 | -1829.25% |
| 2022 | $0.06277 | -67.15% |
| 2021 | $0.19 | -40.17% |
| 2020 | $0.32 | 5.97% |
| 2019 | $0.30 | -124.17% |
| 2018 | -$1.25 | -157.64% |
| 2017 | $2.16 | -691.98% |
| 2016 | -$0.37 | -366.52% |
| 2015 | $0.14 | -74.61% |
| 2014 | $0.54 | 45.12% |
| 2013 | $0.37 | -142.56% |
| 2012 | -$0.87 | 4.42% |
| 2011 | -$0.84 | 18.94% |
| 2010 | -$0.70 | -52.47% |
| 2009 | -$1.48 | -161% |
| 2008 | $2.43 | -205.26% |
| 2007 | -$2.31 | 23.33% |
| 2006 | -$1.87 | 42.13% |
| 2005 | -$1.32 |